Objective: To compare single photon emission computed tomography (SPECT) with planar whole body bone scan (WBBS) in diagnosis of solitary vertebral lesion in non-skeletal malignancies in terms of diagnostic accuracy. Study Design: Cross-sectional study. Place and Duration of Study: Nuclear Medical Centre, Armed Forces Institute of Pathology, Rawalpindi, July 2014 to June 2016. Methodology: After fulfilling the inclusion and exclusion criteria and taking written informed consent, 74 patients of various extra-skeletal malignancies were enrolled in the study. Patients were injected with 740 MBq of 99m Tc-methylene diphosphonate (MDP) intravenously. WBBS images were acquired in anterior and posterior projections 3 hours after injection. SPECT images of the desired vertebral region were acquired subsequently along with low dose CT. All the images were read by two experienced nuclear medicine physicians. Lesions were diagnosed as definitely benign, indeterminate/equivocal and definitely malignant separately on WBBS and SPECT. With SPECT/CT as gold standard, sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) and accuracy were calculated. Results: For planar WBBS, sensitivity was 91.43%, NPV was 86.96%, specificity was 51.28% and PPV remained 62.75%. For SPECT, sensitivity and NPV were 100%, specificity was 92.31% and PPV remained 92.11%. Accuracy remained 70.27% and 95.95% for planar WBBS and SPECT, respectively. Conclusion: SPECT imaging significantly increases the specificity (p <0.05) of 99m Tc-MDP skeletal scintiscanning and accurately diagnoses the equivocal lesions as compared to planar images. 
INTRODUCTION
Diagnosis of distant metastasis is a mainstay in the staging of a malignancy as it determines the course of disease. 1 Skeleton is one of the most common sites of distant metastasis. 2 Most common site of skeletal metastasis is vertebral column (39%), 3 with highest predilection for lumbar spine (52%), followed by dorsal (36%) and the cervical spine (12%). 4 However, it is imperative to rule out coexisting benign etiologies like those in disc, facet joints and pars inter articularis and other sports injuries. 5 Among conventional techniques, plain X-ray can only detect the lesion when there is loss of at least 50% bone substance with an overall sensitivity of around 50%. 1 Presently, WBBS is the investigation of choice for detection of skeletal metastasis, followed by SPECT of indeterminate lesions. Further investigation of equivocal lesions is done with plain X-rays, CT and MRI. 6 CT is highly sensitive for both osteolytic and osteoblastic lesions but not for marrow lesions. Magnetic resonance imaging (MRI) is a high contrast and high resolution technique for localisation of skeletal metastasis including that of bone marrow and their soft tissue extension. 3 SPECT/CT is a well-established hybrid technique that can characterise skeletal lesions as definitely benign or definitely malignant instead of indeterminate or equivocal. 7 However, it puts increased radiation burden on patient in addition to extra cost and issue of nonavailability in our setup. Images were read by two experienced nuclear medicine physicians (with at least 5 years experience). Lesions were classified as definitely benign, equivocal and definitely malignant on both planar WBBS and SPECT. Diagnosis was confirmed on SPECT/CT. The criteria used for diagnosis of benign/malignant lesion on SPECT/CT are summarised in Table I . For the purpose of calculating sensitivity, specificity, NPV, PPV and accuracy, equivocal lesions were considered as malignant.
The data was analysed using SPSS version 20.
Frequencies and percentages were calculated for qualitative variables like gender, type of tumour and location of metastasis. Mean + SD was calculated for quantitative data like age. In addition, frequencies with percentages were calculated for all categorical variables including sensitivity, specificity, negative predictive value, positive predictive value and accuracy with 2 x 2 contingency tables for WBBS and SPECT separately.
Comparison between the two techniques was done using independent t-test, level of significance set at p <0.05.
RESULTS
A total of 74 patients were analysed with ages ranging from 31 years to 77 years (58.66 +10.11 years) with 45.94% (34) females and 54.05% (40) males. Thirty-two (43.2%) patients had carcinoma prostate followed by carcinoma breast in 37.8% (28), lung (9.5%), renal cell (5.4%), medullary thyroid (2.7%) and colorectal (1.4%) carcinomas. Fifty-one (68.9%) patients had lesion identified in lumbar region, 25.7% (19) in thoracic spine, 4.1% (3) in sacrum, and 1.4% (1) spine. On SPECT/CT 66.2% (49) had lesion in vertebral body; out of which, 5 lesions were lytic and 44 were sclerotic. This was followed by facet joint which had lesion in 16.2% (12) patients. Rest of the patients had lesions identified in pedicle (9.5%), disc (5.4%) and transverse and spinous processes (2.8%). 
DISCUSSION
Skeletal scintigraphy with 99m Tc labelled bisphosphonates is a highly sensitive technique for detection of skeletal metastasis that can scan complete skeleton at reasonable cost. 9 However, due to its low specificity, a solitary focal lesion in spine seen on WBBS has 60-70% probability of being metastatic. 10 SPECT adds to the utility of scintigraphy as it improves target to background ratio and the image contrast which improves diagnostic specificity. 11 Incorporation of anatomic imaging like CT further adds to the diagnostic accuracy of SPECT. 12 Addition of SPECT/CT to WBBS significantly enhances sensitivity and specificity while lowering the proportion of indeterminate diagnosis. However, the most important outcome is the modification in patient management plan by up or down staging of disease by more precisely identifying a metastatic lesion. 13 In addition to characterising indeterminate skeletal lesions by accurately demarcating anatomy of pedicles, vertebral bodies, facet joint and intervertebral discs, SPECT/CT can identify lytic lesions, thus differentiating benign from malignant. 7 Studies have shown that a lesion in pedicle has highest (87.7% to 100%) probability to be malignant followed by vertebral body (36.8 -57.3%), spinous process (18.7 -81.3%) and facet joint (0.8 -21.4%). 14 Although, PET and MRI have the ability to detect earliest metastatic infiltrations with quantification, yet their utility is limited, due to non-availability and high cost. 15 FDG PET/CT is more sensitive, specific and accurate technique for detection of skeletal metastases than conventional bone scans, especially in vertebral and pelvic lesions. 16 However, PET/MRI supersedes PET/CT with improved conspicuity in bone metastases detection, though overall detection rate remains same for the two. 17 This study shows the advantage of SPECT over planar WBBS. Sensitivity and NPV remained 100% for SPECT and 91.43% and 86.96%, respectively for WBBS proving both of them to be excellent screening tools. There were a few imitations in this study. Sample size was considerably small with very few patients having lytic lesions. Since lytic lesions were major cause of false negatives on WBBS, more patients with tumors that produce lytic pathologies could have affected the results. Therefore, it is recommended that patients with such tumors should undergo SPECT or preferably SPECT/CT during their metastatic workup. However, those tumors that produce osteoblastic metastasis can be assessed by WBBS aided with SPECT.
CONCLUSION
WBBS and SPECT are highly sensitive techniques for detection of skeletal metastasis. However, WBBS with its low specificity becomes unable to differentiate between metastatic and concurrently occurring benign lesion in vertebral column. SPECT, on the other hand, has reasonably high specificity and can be employed as diagnostic tool for vertebral metastasis instead of SPECT/CT, which remains the gold standard. 
